| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10021;
Beijing Institute of Microbiology and Epidemiology, Beijing, China;
You An Hospital, Capital University of Medical Sciences, Beijing, China; and
Gene Gateway, LLC, Hayward, CA 94545
The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is not only responsible for receptor binding and virus fusion, but also a major Ag among the SARS-CoV proteins that induces protective Ab responses. In this study, we showed that the S protein of SARS-CoV is highly immunogenic during infection and immunizations, and contains five linear immunodominant sites (sites I to V) as determined by Pepscan analysis with a set of synthetic peptides overlapping the entire S protein sequence against the convalescent sera from SARS patients and antisera from small animals immunized with inactivated SARS-CoV. Site IV located in the middle region of the S protein (residues 528–635) is a major immunodominant epitope. The synthetic peptide S603–634, which overlaps the site IV sequence reacted with all the convalescent sera from 42 SARS patient, but none of the 30 serum samples from healthy blood donors, suggesting its potential application as an Ag for developing SARS diagnostics. This study also provides information useful for designing SARS vaccines and understanding the SARS pathogenesis.
This article has been cited by other articles:
|
|
 |
|
  Y. He, S. J. Barker, A. J. MacDonald, Y. Yu, L. Cao, J. Li, R. Parhar, S. Heck, S. Hartmann, D. T. Golenbock, et al. Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells J. Immunol., April 1, 2009; 182(7): 4005 - 4016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Vlasova, X. Zhang, M. Hasoksuz, H. S. Nagesha, L. M. Haynes, Y. Fang, S. Lu, and L. J. Saif Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nucleoprotein J. Virol., December 15, 2007; 81(24): 13365 - 13377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhou, D. Xu, X. Li, H. Li, M. Shan, J. Tang, M. Wang, F.-S. Wang, X. Zhu, H. Tao, et al. Screening and Identification of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific CTL Epitopes J. Immunol., August 15, 2006; 177(4): 2138 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Kang, B.-a. Yang, Y. Hu, H. Zhao, W. Xiong, Y. Yang, B. Si, and Q. Zhu Human Neutralizing Fab Molecules against Severe Acute Respiratory Syndrome Coronavirus Generated by Phage Display. Clin. Vaccine Immunol., August 1, 2006; 13(8): 953 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. He, J. Li, S. Heck, S. Lustigman, and S. Jiang Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design. J. Virol., June 1, 2006; 80(12): 5757 - 5767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. He, J. Li, W. Li, S. Lustigman, M. Farzan, and S. Jiang Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein J. Immunol., May 15, 2006; 176(10): 6085 - 6092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Li, S.-K. Wong, F. Li, J. H. Kuhn, I-C. Huang, H. Choe, and M. Farzan Animal Origins of the Severe Acute Respiratory Syndrome Coronavirus: Insight from ACE2-S-Protein Interactions J. Virol., May 1, 2006; 80(9): 4211 - 4219. [Full Text] [PDF]
|
|
|
|
 |
|
 S C S Chow, C Y S Ho, T T Y Tam, C Wu, T Cheung, P K S Chan, M H L Ng, P K Hui, H K Ng, D M Y Au, et al. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients J. Clin. Pathol., May 1, 2006; 59(5): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maache, F. Komurian-Pradel, A. Rajoharison, M. Perret, J.-L. Berland, S. Pouzol, A. Bagnaud, B. Duverger, J. Xu, A. Osuna, et al. False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid-Based Western Blot Assay Were Rectified by the Use of Two Subunits (S1 and S2) of Spike for Detection of Antibody to SARS-CoV. Clin. Vaccine Immunol., March 1, 2006; 13(3): 409 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhong, Z. Guo, H. Yang, L. Peng, Y. Xie, T.-Y. Wong, S.-T. Lai, and Z. Guo Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients J. Gen. Virol., February 1, 2006; 87(2): 369 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Yi, L. Ba, L. Zhang, D. D. Ho, and Z. Chen Single Amino Acid Substitutions in the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Determine Viral Entry and Immunogenicity of a Major Neutralizing Domain J. Virol., September 15, 2005; 79(18): 11638 - 11646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. He, Y. Zhou, P. Siddiqui, J. Niu, and S. Jiang Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus J. Clin. Microbiol., August 1, 2005; 43(8): 3718 - 3726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. He, H. Lu, P. Siddiqui, Y. Zhou, and S. Jiang Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing Antibodies J. Immunol., April 15, 2005; 174(8): 4908 - 4915. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
